Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Early diagnosis of prostate cancer by citrate determination in urine with europium-oxytetracycline complex.

Silva FR, Nabeshima CT, Bellini MH, Courrol LC.

Appl Spectrosc. 2012 Aug;66(8):958-61. doi: 10.1366/11-06546. Epub 2012 Jul 13.

PMID:
22800985
2.

Determination of adenosine disodium triphosphate (ATP) using oxytetracycline-Eu3+ as a fluorescence probe by spectrofluorimetry.

Hou F, Miao Y, Jiang C.

Spectrochim Acta A Mol Biomol Spectrosc. 2005 Oct;61(13-14):2891-5. Epub 2004 Dec 16.

PMID:
16165028
3.

Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy.

Kurhanewicz J, Vigneron DB, Nelson SJ, Hricak H, MacDonald JM, Konety B, Narayan P.

Urology. 1995 Mar;45(3):459-66.

PMID:
7533458
4.

Effect of sildenafil citrate on an orthotopic prostate cancer growth and metastasis model.

Qian CN, Takahashi M, Kahnoski R, Teh BT.

J Urol. 2003 Sep;170(3):994-7.

PMID:
12913757
5.

Chemical speciation of trivalent actinides and lanthanides in biological fluids: the dominant in vitro binding form of curium(III) and europium(III) in human urine.

Heller A, Barkleit A, Bernhard G.

Chem Res Toxicol. 2011 Feb 18;24(2):193-203. doi: 10.1021/tx100273g. Epub 2010 Dec 13.

PMID:
21142120
6.

Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein.

Rogers CG, Yan G, Zha S, Gonzalgo ML, Isaacs WB, Luo J, De Marzo AM, Nelson WG, Pavlovich CP.

J Urol. 2004 Oct;172(4 Pt 1):1501-3.

PMID:
15371879
7.

Spectrofluorimetric determination of bilirubin in serum samples.

Bian W, Zhang N, Jiang C.

Luminescence. 2011 Jan-Feb;26(1):54-8. doi: 10.1002/bio.1185. Epub 2010 Jan 21.

PMID:
20094982
8.

DNA-based detection of prostate cancer in urine after prostatic massage.

Goessl C, Müller M, Heicappell R, Krause H, Straub B, Schrader M, Miller K.

Urology. 2001 Sep;58(3):335-8.

PMID:
11549474
9.

The diagnostic value of PCA3 gene-based analysis of urine sediments after digital rectal examination for prostate cancer in a Chinese population.

Shen M, Chen W, Yu K, Chen Z, Zhou W, Lin X, Weng Z, Li C, Wu X, Tao Z.

Exp Mol Pathol. 2011 Feb;90(1):97-100. doi: 10.1016/j.yexmp.2010.10.009. Epub 2010 Oct 20.

PMID:
20970419
10.

Bioenergetic theory of prostate malignancy.

Costello LC, Franklin RB.

Prostate. 1994 Sep;25(3):162-6.

PMID:
7520580
11.

Prevention of human PC-346C prostate cancer growth in mice by a xenogeneic tissue vaccine.

Suckow MA, Rosen ED, Wolter WR, Sailes V, Jeffrey R, Tenniswood M.

Cancer Immunol Immunother. 2007 Aug;56(8):1275-83. Epub 2007 Jan 23.

PMID:
17242926
12.

Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study.

Kurhanewicz J, Dahiya R, Macdonald JM, Chang LH, James TL, Narayan P.

Magn Reson Med. 1993 Feb;29(2):149-57.

PMID:
8429778
13.

The lily-of-the-valley fragrance receptor--potential in prostate cancer imaging.

Sturzu A, Echner H, Heckl S.

Prostate. 2009 Nov 1;69(15):1599-602. doi: 10.1002/pros.21009.

PMID:
19670218
15.
16.

Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer.

Jerónimo C, Usadel H, Henrique R, Silva C, Oliveira J, Lopes C, Sidransky D.

Urology. 2002 Dec;60(6):1131-5.

PMID:
12475696
17.

Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression.

Soares CR, Shibata MA, Green JE, Jorcyk CL.

Neoplasia. 2002 Mar-Apr;4(2):112-20.

19.

Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice.

Bylund A, Zhang JX, Bergh A, Damber JE, Widmark A, Johansson A, Adlercreutz H, Aman P, Shepherd MJ, Hallmans G.

Prostate. 2000 Mar 1;42(4):304-14.

PMID:
10679760

Supplemental Content

Support Center